BioSpace News Archive

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT) today announced positive topline results from a multi-dose pharmacokinetic (“PK”) study for OPNT003, nasal nalmefene, an investigational treatment for opioid overdose.

ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2021 financial results.

Insmed Incorporated today announced that management will present at the SVB Leerink Virtual 11th Annual Global Healthcare Conference on February 18, 2022 at 10:00 a.m. ET.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the first completed surgery using its JOURNEY II Medial Dished (MD) System for total knee arthroplasty (TKA).

Chemomab Therapeutics Ltd today announced that it will present a company overview at the Aegis Capital Corp. Virtual Conference on February 24, 2022, at 9:00 am ET.

LENSAR, Inc., a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, announced Nick Curtis, Chief Executive Officer, will participate in two upcoming investor conferences.

Imara Inc. announced that Rahul Ballal, Ph.D., President and Chief Executive Officer, will participate in a Fireside Chat at the 11th Annual SVB Leerink Global Healthcare Conference taking place virtually on Thursday, February 17, 2022 at 3:40 p.m. ET.

Voyager Therapeutics, Inc. a gene therapy company developing life-changing treatments and next-generation adeno-associated virus technologies, announced that it will participate in the following virtual investor conferences.

Quris, an artificial intelligence innovator disrupting the pharmaceutical arena, announced it has signed an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, allowing Merck KGaA, Darmstadt, Germany to assess Quris’ BioAI safety prediction platform, comparing it to traditional in vitro and in vivo approaches.

Owning to the increase in geriatric population and various kinds of diseases associated with old age, the global minimally invasive surgical instruments market is expected to see a strong growth in the coming years.